\-\ Texto\\:\\ \ \(0\)\
\-\ unremarkable\\.\\ cea\\ \\(at\\ time\\ of\\ s\\/p\\ 4\\ cycle\\ scan\\)\\:\\ 4\\.5\\ ng\\/ml\\ \\(normal\\)\ \(0\)\
\-\ given\\ the\\ finding\\ of\\ disease\\ recurrence\\ \\(versus\\ persistence\\)\\,\\ patient\\ was\\ taken\\ to\\ or\\ and\\ the\\ metastasis\\ resected\\.\ \(0\)\
\-\ the\\ routine\\ 1\\ hour\\ post\\-injection\\ images\\ are\\ normal\\.\\ \\ no\\ hypermetabolism\\ is\\ seen\\ within\\ the\\ liver\\.\\ \\ delayed\\ \\(dual\\ time\\ point\\)\\ images\\ now\\ demonstrate\\ a\\ focus\\ of\\ hypermetabolism\\ within\\ the\\ liver\\-\\-at\\ the\\ same\\ location\\ as\\ the\\ previous\\ abnormality\\.\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ tumor\\ recurrence\\ vs\\.\\ persistent\\ tumor\ \(0\)\
\-\ denovo\\ tumor\ \(0\)\
\-\ artifact\ \(93\)\
\-\ patient\\ has\\ history\\ of\\ colon\\ cancer\\,\\ with\\ ct\\ negative\\ for\\ metastatic\\ disease\\.\\ \\ he\\ was\\ treated\\ with\\ hemicolectomy\\,\\ after\\ which\\ time\\ a\\ pet\\/ct\\ was\\ performed\\,\\ revealing\\ an\\ unsuspected\\ hypermetabolic\\ focus\\ in\\ the\\ liver\\.\\ \\ he\\ underwent\\ 4\\ cycles\\ of\\ chemotherapy\\,\\ and\\ had\\ a\\ subsequently\\ negative\\ pet\\/ct\\ at\\ that\\ time\\.\\ \\ a\\ follow\\ up\\ pet\\/ct\\ was\\ performed\\ two\\ months\\ later\\,\\ which\\ is\\ this\\ case\\.\\.\\.\\.\ \(0\)\
\-\ the\\ initial\\ scan\\ was\\ negative\\ for\\ disease\\ recurrence\\.\\ it\\ was\\ only\\ after\\ delayed\\ imaging\\ that\\ the\\ abnormality\\ became\\ apparent\\.\\ \\ delayed\\ images\\ were\\ not\\ performed\\ on\\ the\\ prior\\ \\"negative\\"\\ exam\\ after\\ the\\ 4th\\ cycle\\ of\\ chemotherapy\\,\\ so\\ it\\ is\\ impossible\\ to\\ tell\\ if\\ the\\ abnormality\\ would\\ have\\ also\\ been\\ present\\ at\\ that\\ time\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pet\\/ct\\:\\ 0\\.08328365758451302\ \(0\)\
\-\ hypermetabolism\\:\\ 0\\.07015369213907625\ \(0\)\
\-\ time\\:\\ 0\\.054854573346348016\ \(0\)\
\-\ cycle\\:\\ 0\\.050878569082711794\ \(0\)\
\-\ recurrence\\:\\ 0\\.05083530121001065\ \(0\)\
\-\ delayed\\:\\ 0\\.04742700469452518\ \(0\)\
\-\ negative\\:\\ 0\\.04640218475227044\ \(0\)\
\-\ abnormality\\:\\ 0\\.042989426506780254\ \(0\)\
\-\ liver\\:\\ 0\\.04017574787499168\ \(0\)\
\-\ denovo\\:\\ 0\\.04007053829075681\ \(0\)\
\-\ post\\-injection\\:\\ 0\\.0369198692882116\ \(0\)\
\-\ focus\\:\\ 0\\.034898042559508395\ \(0\)\
\-\ unsuspected\\:\\ 0\\.0337692002856664\ \(0\)\
\-\ performed\\:\\ 0\\.03248970451673617\ \(0\)\
\-\ impossible\\:\\ 0\\.03192617706699292\ \(0\)\
\-\ \\.\\.\\.\\.\\:\\ 0\\.031225492158687203\ \(0\)\
\-\ tell\\:\\ 0\\.031225492158687203\ \(0\)\
\-\ hypermetabolic\\:\\ 0\\.02917101432349149\ \(0\)\
\-\ hemicolectomy\\:\\ 0\\.028775508064447716\ \(0\)\
\-\ cea\\:\\ 0\\.028074823156141997\ \(0\)\
\-\ cycles\\:\\ 0\\.028074823156141997\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.027844961683098773\ \(0\)\
\-\ tumor\\:\\ 0\\.0271668041128747\ \(0\)\
\-\ was\\:\\ 0\\.026953023333100547\ \(0\)\
\-\ dual\\:\\ 0\\.02645357341096594\ \(0\)\
\-\ 4\\.5\\:\\ 0\\.02623179993746852\ \(0\)\
\-\ ng\\/ml\\:\\ 0\\.02581829185471522\ \(0\)\
\-\ persistence\\:\\ 0\\.02581829185471522\ \(0\)\
\-\ disease\\:\\ 0\\.02539522802210371\ \(0\)\
\-\ revealing\\:\\ 0\\.025089461627100768\ \(0\)\
\-\ after\\:\\ 0\\.024109107308307304\ \(0\)\
\-\ images\\:\\ 0\\.0223535985265821\ \(0\)\
\-\ scan\\:\\ 0\\.02174792236757253\ \(0\)\
\-\ he\\:\\ 0\\.02167443038211836\ \(0\)\
\-\ 4\\:\\ 0\\.02164519913799132\ \(0\)\
\-\ hour\\:\\ 0\\.021238107716249843\ \(0\)\
\-\ at\\:\\ 0\\.021050239142393325\ \(0\)\
\-\ became\\:\\ 0\\.020958299111706966\ \(0\)\
\-\ artifact\\:\\ 0\\.02063114684068383\ \(0\)\
\-\ that\\:\\ 0\\.020127009934893046\ \(0\)\
\-\ 4th\\:\\ 0\\.019566631442952946\ \(0\)\
\-\ metastatic\\:\\ 0\\.019555540032873547\ \(0\)\
\-\ resected\\:\\ 0\\.01922977702407239\ \(0\)\
\-\ versus\\:\\ 0\\.018463310149364243\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.017841678617021565\ \(0\)\
\-\ so\\:\\ 0\\.017673930630951334\ \(0\)\
\-\ subsequently\\:\\ 0\\.017608527278896335\ \(0\)\
\-\ it\\:\\ 0\\.017462258041209242\ \(0\)\
\-\ apparent\\:\\ 0\\.017175299188876676\ \(0\)\
\-\ point\\:\\ 0\\.016973245722645615\ \(0\)\
\-\ s\\/p\\:\\ 0\\.01629277185050869\ \(0\)\
\-\ taken\\:\\ 0\\.01619656816327213\ \(0\)\
\-\ same\\:\\ 0\\.016010061814736392\ \(0\)\
\-\ routine\\:\\ 0\\.015574757700681806\ \(0\)\
\-\ persistent\\:\\ 0\\.015492484784119905\ \(0\)\
\-\ vs\\:\\ 0\\.01529309077454908\ \(0\)\
\-\ colon\\:\\ 0\\.015254240499192452\ \(0\)\
\-\ previous\\:\\ 0\\.015083409993969527\ \(0\)\
\-\ within\\:\\ 0\\.014819376439873468\ \(0\)\
\-\ metastasis\\:\\ 0\\.014539760574090574\ \(0\)\
\-\ which\\:\\ 0\\.014501314429477715\ \(0\)\
\-\ later\\:\\ 0\\.01402463018633147\ \(0\)\
\-\ would\\:\\ 0\\.013822576720100408\ \(0\)\
\-\ location\\:\\ 0\\.013548671304108605\ \(0\)\
\-\ underwent\\:\\ 0\\.01332816379762827\ \(0\)\
\-\ given\\:\\ 0\\.013315519965983375\ \(0\)\
\-\ now\\:\\ 0\\.013277798135007488\ \(0\)\
\-\ \\(\\:\\ 0\\.013133849568070191\ \(0\)\
\-\ \\)\\:\\ 0\\.012973412583878274\ \(0\)\
\-\ initial\\:\\ 0\\.012870827923996854\ \(0\)\
\-\ unremarkable\\:\\ 0\\.012859392812191185\ \(0\)\
\-\ cancer\\:\\ 0\\.012768933019839841\ \(0\)\
\-\ finding\\:\\ 0\\.012518461386538551\ \(0\)\
\-\ follow\\:\\ 0\\.0123418157815747\ \(0\)\
\-\ normal\\:\\ 0\\.012178295041810009\ \(0\)\
\-\ only\\:\\ 0\\.011679143902204252\ \(0\)\
\-\ treated\\:\\ 0\\.011626594709472087\ \(0\)\
\-\ two\\:\\ 0\\.011124232898254571\ \(0\)\
\-\ months\\:\\ 0\\.010608824066773033\ \(0\)\
\-\ been\\:\\ 0\\.010567249497563595\ \(0\)\
\-\ if\\:\\ 0\\.01053974288082107\ \(0\)\
\-\ up\\:\\ 0\\.010444759777519196\ \(0\)\
\-\ prior\\:\\ 0\\.009973239873647106\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.009546068352871896\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.009362497736282923\ \(0\)\
\-\ 1\\:\\ 0\\.00924239258163503\ \(0\)\
\-\ imaging\\:\\ 0\\.009100335565707284\ \(0\)\
\-\ demonstrate\\:\\ 0\\.008938418824241094\ \(0\)\
\-\ were\\:\\ 0\\.00881948334859055\ \(0\)\
\-\ present\\:\\ 0\\.008772767063325821\ \(0\)\
\-\ \\,\\:\\ 0\\.008613502084640961\ \(0\)\
\-\ exam\\:\\ 0\\.008532881545225173\ \(0\)\
\-\ case\\:\\ 0\\.008497747422123957\ \(0\)\
\-\ have\\:\\ 0\\.00841108217438678\ \(0\)\
\-\ had\\:\\ 0\\.008381135542003218\ \(0\)\
\-\ the\\:\\ 0\\.008169275914305161\ \(0\)\
\-\ patient\\:\\ 0\\.007787199371967163\ \(0\)\
\-\ seen\\:\\ 0\\.007675580068489501\ \(0\)\
\-\ is\\:\\ 0\\.0076676015234280765\ \(0\)\
\-\ also\\:\\ 0\\.0076573617894097785\ \(0\)\
\-\ has\\:\\ 0\\.00729409077497399\ \(0\)\
\-\ a\\:\\ 0\\.007210905487610932\ \(0\)\
\-\ for\\:\\ 0\\.006628255896751955\ \(0\)\
\-\ as\\:\\ 0\\.005875352299518763\ \(0\)\
\-\ not\\:\\ 0\\.005612812144281524\ \(0\)\
\-\ ct\\:\\ 0\\.0054331984245092856\ \(0\)\
\-\ an\\:\\ 0\\.005371203928566953\ \(0\)\
\-\ history\\:\\ 0\\.005364611535032197\ \(0\)\
\-\ are\\:\\ 0\\.005294881238770917\ \(0\)\
\-\ \\:\\:\\ 0\\.005137612799957568\ \(0\)\
\-\ or\\:\\ 0\\.004552376131653216\ \(0\)\
\-\ this\\:\\ 0\\.004368805515064241\ \(0\)\
\-\ no\\:\\ 0\\.003911109775926372\ \(0\)\
\-\ to\\:\\ 0\\.003882437349481693\ \(0\)\
\-\ on\\:\\ 0\\.0032904136925701274\ \(0\)\
\-\ of\\:\\ 0\\.0031773763853996844\ \(0\)\
\-\ \\.\\:\\ 0\\.001936338332582524\ \(0\)\
\-\ in\\:\\ 0\\.001915441955182977\ \(0\)\
\-\ and\\:\\ 0\\.0016364455066565312\ \(0\)\
\-\ with\\:\\ 0\\.0010636743280899067\ \(0\)\
